Snippet Search

Searching 12,404,397 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 995 matching articles

Results per page:

... combinations of 5-fluorouracil +   mitomycin 
Pharmacotherapy of Anal Cancer
Pharmacotherapy of Anal Cancer
Rogers, Jane E.; Eng, Cathy
or 5-fluorouracil + cisplatin, along with ...
... various chemotherapeutic drugs, such as  mitomycin 
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
Braam, H. J.; Hoogwater, F. J. H.
or cisplatin, are used for HIPEC. ...
... IV (DPPIV) − host rats are pretreated with  mitomycin 
Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat
Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat
Sanders, Jennifer A.
CMitomycin C to prevent adult hepatocyte ...
... following intraoperative administration of  mitomycin 
Mitomycin
Mitomycin
0.02% [routes, dosages and outcomes not ...
... led to the first reports of HIPEC using  mitomycin 
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Mehta, Akash M.; Huitema, Alwin D. R.; Burger, Jacobus W. A.; Brandt-Kerkhof, Alexandra R. M.; Heuvel, Sander F.; Verwaal, Victor J.
C for patients with peritoneal ...
... growth-arrest with the cost-effective  Mitomycin 
An optimization protocol for Swiss 3T3 feeder cell growth-arrest by Mitomycin C dose-to-volume derivation strategy
An optimization protocol for Swiss 3T3 feeder cell growth-arrest by Mitomycin C dose-to-volume derivation strategy
Chugh, Rishi Man; Chaturvedi, Madhusudan; Yerneni, Lakshmana Kumar
C vis-à-vis irradiation is controversial ...
... lines for LMBC). HAIC protocols included  mitomycin 
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters
Tewes, Mitra; Peis, Michael Wilhelm; Bogner, Simon; Theysohn, Jens M.; Reinboldt, Marcus Paul; Schuler, Martin; Welt, Anja
/5-FU (70%), ...
... anal margin, ESMO suggests treatment with  Mitomycin 
Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review
Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review
Johnson, Natalie; Pellino, Gianluca; Simillis, Constantinos; Qiu, Shengyang; Nikolaou, Stella; Baird, Daniel L.; Rasheed, Shahnawaz; Tekkis, Paris P.; Kontovounisios, Christos
/5-FU and radiotherapy. ...
... patients were treated with intraperitoneal  mitomycin 
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades
Ihemelandu, Chukwuemeka; Sugarbaker, Paul H.
C and 5-FU during the perioperative ...
... than expected after CS-HIPEC with  mitomycin 
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C
Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C
Lange, Krystle N.; McKay, Danielle; Gentry, Brian G.; Franko, Jan
C (MMC), they investigated the ...
... focus on myeloid suppressor cell therapy by  mitomycin 
Cell therapeutic approaches to immunosuppression after clinical kidney transplantation
Cell therapeutic approaches to immunosuppression after clinical kidney transplantation
Morath, Christian; Schmitt, Anita; Kälble, Florian; Zeier, Martin; Schmitt, Michael; Sandra-Petrescu, Flavius; Opelz, Gerhard; Terness, Peter; Schaier, Matthias; Kleist, Christian
C-induced cells (MICs). ...
... and chemotherapy with 5-fluorouracil and  mitomycin 
Long-standing Crohn’s disease and its implication on anal squamous cell cancer management
Long-standing Crohn’s disease and its implication on anal squamous cell cancer management
Lightner, Amy L; Moncrief, Sara B.; Smyrk, Thomas C.; Pemberton, John H.; Haddock, Michael G.; Larson, David W.; Dozois, Eric J.; Mathis, Kellie L.
; one patient received cisplatin rather ...
... sp. TM1040 harbor one and three  mitomycin 
Genomic, proteomic and bioinformatic analysis of two temperate phages in Roseobacter clade bacteria isolated from the deep-sea water
Genomic, proteomic and bioinformatic analysis of two temperate phages in Roseobacter clade bacteria isolated from the deep-sea water
Tang, Kai; Lin, Dan; Zheng, Qiang; Liu, Keshao; Yang, Yujie; Han, Yu; Jiao, Nianzhi
C-inducible prophages, respectively [21, ...
... Komplikation nach Trabekulektomie mit  Mitomycin 
Frühe Bindehautatrophie nach Trabekulektomie mit Mitomycin-C-Applikation und Kollagen-Matrix-Implantation
Frühe Bindehautatrophie nach Trabekulektomie mit Mitomycin-C-Applikation und Kollagen-Matrix-Implantation
Siggel, R.; Dietlein, T.
-C-Applikation und subkonjunktivaler ...
... reported along with the administration of  mitomycin 
Developments and current approaches in the treatment of pterygium
Developments and current approaches in the treatment of pterygium
Hacıoğlu, Dilek; Erdöl, Hidayet
C, 5-FU and other agents that were used as ...
... 5 × 103 J/m2, hydrogen peroxide (50 mM) and  mitomycin 
Radio-protective and antioxidative activities of astaxanthin from newly isolated radio-resistant bacterium Deinococcus sp. strain WMA-LM9
Radio-protective and antioxidative activities of astaxanthin from newly isolated radio-resistant bacterium Deinococcus sp. strain WMA-LM9
Sajjad, Wasim; Ahmad, Manzoor; Khan, Salman; Ilyas, Sunniya; Hasan, Fariha; Celik, Cem; McPhail, Kerry; Shah, Aamer Ali
C (10 μg/ml). ...
... region. This DNA demethylation occurred in  mitomycin 
RUNX1 induces DNA replication independent active DNA demethylation at SPI1 regulatory regions
RUNX1 induces DNA replication independent active DNA demethylation at SPI1 regulatory regions
Goyal, Shubham; Suzuki, Takahiro; Li, Jing-Ru; Maeda, Shiori; Kishima, Mami; Nishimura, Hajime; Shimizu, Yuri; Suzuki, Harukazu
-C-treated nonproliferating cells at both ...
... developed. One such cytostatic agent is  mitomycin 
Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C
Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C
Prasad, Narasimha N. G.; Muddukrishna, Shammana N.
C (MM). ...
... III trial compared chemohyperthermia using  mitomycin 
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Kamat, Ashish M.; Bellmunt, Joaquim; Galsky, Matthew D.; Konety, Badrinath R.; Lamm, Donald L.; Langham, David; Lee, Cheryl T.; Milowsky, Matthew I.; O’Donnell, Michael A.; O’Donnell, Peter H.; Petrylak, Daniel P.; Sharma, Padmanee; Skinner, Eila C.; Sonpavde, Guru; Taylor, John A., III; Abraham, Prasanth; Rosenberg, Jonathan E.
C (MMC) versus BCG as adjuvant therapy for ...
... perforation following treatment with  mitomycin 
Mitomycin
Mitomycin
[ ...
... or intralesional injection of steroids or  mitomycin 
Endoscopic Management of Benign Esophageal Strictures
Endoscopic Management of Benign Esophageal Strictures
Ravich, William J.
C. ...
... received hyperthermic intraperitoneal  mitomycin 
Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites
Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites
Sugarbaker, Paul H.
C (15 mg/m2) and doxorubicin (15 mg/m2) and ...
... 625 mg/m2 bid on treatment days and  mitomycin 
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
Gordeyev, Sergey S.; Rasulov, Arsen O.; Gorbounova, Vera A.; Tkachev, Sergey I.; Glebovskaya, Valeriya V.; Fedyanin, Mikhail Yu.; Besova, Nataliya S.; Surayeva, Yulia E.
C 10 g/m2 on day 1. ...
... lässt sich vermutlich senken, wenn dabei  Mitomycin 
Zytostatikum stabilisiert Erfolg der Harnröhrenschlitzung
Zytostatikum stabilisiert Erfolg der Harnröhrenschlitzung
Schumacher, Beate
C in die Läsion injiziert wird. ...
... and top agar from Oxoid (Basingstoke, UK).  Mitomycin 
Two dechlorinated chlordecone derivatives formed by in situ chemical reduction are devoid of genotoxicity and mutagenicity and have lower proangiogenic properties compared to the parent compound
Two dechlorinated chlordecone derivatives formed by in situ chemical reduction are devoid of genotoxicity and mutagenicity and have lower proangiogenic properties compared to the parent compound
Legeay, Samuel; Billat, Pierre-André; Clere, Nicolas; Nesslany, Fabrice; Bristeau, Sébastien; Faure, Sébastien; Mouvet, Christophe
C (CAS Registry Number: 50–07-7), ...